Drug class in one race
IL-17A/F drugs for Psoriatic Arthritis
2 tracked IL-17A/F drugs in the Psoriatic Arthritis race. The class explanation lives on the IL-17A/F page; the full indication pipeline across every mechanism is on the Psoriatic Arthritis page.
1 approved / phase 41 Phase 3
Head-to-head evidence: bimekizumab vs sonelokimab